Stocks Health care INSM
NASDAQ · Health careINSMED Inc (INSM)
INSMED Inc brought in $1.5B of revenue over the twelve months to September 30, 2026, up 240.0% from a year earlier. It posted a net loss of $605.6M. In fiscal 2025 capital spending exceeded operating cash flow by $967.6M. At September 30, 2026 it held $396.6M in cash against $546.8M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 29, 2026.
Key facts about INSMED Inc
- Net worth
- INSMED Inc has a market value (market cap) of $25.8B at the latest share price, and shareholders' equity of $726.2M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $606.4M (+66.7% year on year), with a net loss of $1.3B. Over the 12 months to September 30, 2026: revenue $1.5B, net loss $605.6M.
- Cash flow
- In fiscal 2025 operations used $935M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 29, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- INSMED Inc's next report is expected around February 18, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What INSMED Inc does
INSMED Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker INSM.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $606.4M | -$1.3B | -$6.42 | -$967.6M |
| 2024 | $363.7M | -$913.8M | -$5.57 | -$705.8M |
| 2023 | $305.2M | -$749.6M | -$5.34 | -$549.5M |
| 2022 | $245.4M | -$481.5M | -$3.91 | -$410.3M |
| 2021 | $188.5M | -$434.7M | -$3.88 | -$370.6M |
| 2020 | $164.4M | -$294.1M | -$3.01 | -$225.6M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where INSM ranks in Health care
Latest SEC filings
What INSMED Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 29, 2026
- October 29, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 268% to $524.4M versus the same quarter last year; diluted EPS -$0.46 versus -$1.75.
- October 20, 2026
- October 5, 2026Executive or director change8-KInsmed Chief Financial Officer Sara Bonstein will step down effective October 30, 2026, while the company reaffirmed its full-year 2026 financial guidance.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 296% to $425.5M versus the same quarter last year; diluted EPS -$0.06 versus -$1.70.
- July 22, 2026Passive stake changed SCHEDULE 13G/A
- July 16, 2026
Insider trades
What the people running INSMED Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $3.7M worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 19, 2026 | Koppikar UtpalDirector | Received as pay | 6,139 | - |
| October 19, 2026 | Hudson PaulDirector | Received as pay | 6,139 | - |
| September 9, 2026 | Brennan David RDirector | Sold | 25,000 | $3.1M |
| August 17, 2026 | Sharoky Melvin MdDirector | Soldindirect | 5,000 | $637.7K |
| August 10, 2026 | Adsett RogerChief Operating Officer | Exercised options | 82,280 | $1.1M |
| August 10, 2026 | Adsett RogerChief Operating Officer | Exercised options | 76,600 | $1.3M |
| August 10, 2026 | Adsett RogerChief Operating Officer | Exercised options | 80,970 | $2.5M |
| August 10, 2026 | Adsett RogerChief Operating Officer | Sold | 239,850 | $32M |
Who owns INSM
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Fmr LLC13G, passive with 1 related filers | 7.4% | August 6, 2026 |
| Vanguard Capital Management13G, passive | 5.34% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 665 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Fmr LLC | 16,143,583 | +2,983,416 |
| BlackRock, Inc. | 15,807,984 | -870,162 |
| Vanguard Portfolio Management LLC | 10,407,962 | +36,160 |
| Jpmorgan Chase & Co | 10,428,170 | -13,722,329 |
| Vanguard Capital Management LLC | 9,790,865 | +148,734 |
| Baker Bros. Advisors LP | 8,796,111 | +1,375,000 |
| Capital International Investors | 8,238,124 | +2,642,930 |
| Darwin Global Management, Ltd. | 6,431,163 | -10,374,021 |
| Ameriprise Financial Inc | 6,179,571 | +3,121,853 |
| Orbis Allan Gray Ltd | 6,076,487 | +4,203,663 |
| State Street Corp | 6,052,174 | +500,475 |
| D. E. Shaw & Co., Inc. | 5,877,959 | +252,134 |
| Artisan Partners Limited Partnership | 5,441,718 | -1,085,583 |
| Rtw Investments, LP | 4,842,880 | 0 |
| Geode Capital Management, LLC | 4,220,155 | -230,234 |
| Norges Bank | 3,377,641 | new |
| Jupiter Topco LLC | 2,605,181 | new |
| UBS Group AG | 2,584,446 | +846,965 |
| Citadel Advisors LLC | 2,556,973 | +374,402 |
| Franklin Resources Inc | 2,273,222 | -344,029 |
Insiders
16 insiders reported holding 1,226,373 shares in total, about $144.6M at the last price.
| Holder | Shares |
|---|---|
| Lewis WilliamChair and CEO, Director | 259,058 |
| Sharoky Melvin MdDirector | 246,081 |
| Adsett RogerChief Operating Officer | 98,744 |
| Mcgirr David W JDirector | 97,72353,400 held indirectly |
| Desjardins ClarissaDirector | 70,312 |
| Bonstein SaraChief Financial Officer | 69,082 |
| Schafer CarolDirector | 66,622 |
| Anderson Elizabeth MDirector | 62,034 |
| Flammer Martina M.D.Chief Medical Officer | 60,486 |
| Lee LeoDirector | 57,971 |
Questions about INSM
What does INSMED Inc do?
INSMED Inc is a company in the Health care sector, listed on NASDAQ as INSM. Its shares trade on NASDAQ under the ticker INSM.
What is INSMED Inc's net worth?
INSMED Inc has a market value (market cap) of $25.8B at the latest share price, and shareholders' equity of $726.2M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is INSMED Inc profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $605.6M on revenue of $1.5B.
How much revenue does INSMED Inc make?
Over the twelve months to September 30, 2026 INSMED Inc reported revenue of $1.5B. That is 240.0% more than a year earlier.
When did INSMED Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on October 29, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the planned insider sale from November 3, 2026.
When is INSMED Inc's next earnings report?
INSMED Inc's next report is expected around February 18, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare INSM with
Follow INSM
Get an email when INSMED Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values INSMED Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.